Saltar al contenido principal

Progress in Medicinal Chemistry

  • 1 Edición, Volumen 42 - 15 de abril de 2004
  • Última edición
  • Autor: F.D. King
  • Idioma: Inglés

This volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of an… Leer más

Descripción

This volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of anti-inflammatory and antiapoptotic agents of potential value in rheumatoid arthritis; and a survey of semi-synthetic and totally synthetic antibiotics and anti-HIV agents and their sites of interaction; the development of inhibitors of the intracellular enzyme acyl-CoA: cholesterol O-acyltransferase (ACAT) for the treatment of hypercholesterolemia; a description of recent progress in growth hormone secretagogues, with the focus on strategies to improve oral bioavailability and duration of action; and information on inhibition of the proteolytic enzyme, hepatitis C protease N-3(NS3), (required for vital replication) as one of the most attractive targets for HCV infections.

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 42
  • Publicado: 15 de abril de 2004
  • Idioma: Inglés

Sobre el autor

FK

F.D. King

Afiliaciones y experiencia
SmithKIine Beecham Pharmaceuticals New Frontiers Science Park (North) Third Avenue

Ver libro en ScienceDirect

Lee Progress in Medicinal Chemistry en ScienceDirect